Endocrine T2DM Flashcards
(89 cards)
TYPE 2 DIABETES is characterised by…?
Insulin resistance, later in life
Prediabeties is what mmol/L?
42-47mmol/mol
Can try prevent diabetes with lifestyle advice
Diabetes HbA1c?
48mmol/mol
DIABETES TREATMENT- pts with LOW CVD RISK
What 3 do you need to assess first?
HbA1c
Kidney function
Cardiovascular risk
AIM FOR INDIVDUALLY AGREED THRESHOLDS!
DIABETES TREATMENT- LOW CVD RISK
1st LINE?
METFORMIN
DIABETES TREATMENT- LOW CVD RISK
Metformin not working and
HBA1C> individually agreed threshold, what meds to add?
DUAL THERAPY
ADD IN…
DPP-4i (gliptin)
OR
Pioglitazone (not in HF)
OR
SU (Sulphonylurea- glic, glim, tolb)
OR
SGLT-2i (Flozins)
DIABETES TREATMENT- LOW CVD RISK
DUAL THERAPY not working..
HBA1C> individually agreed threshold, how to treat?
TRIPLE THERAPY by…
adding/swapping class of anti-diabetic
NOTE: DAPAG with PIOG not recommended, OTHER SGLT-2is fine
DIABETES TREATMENT- HIGH CVD RISK
Which pts high risk?
Established atherosclerotic CVD
HF
QRISK2>10%
DIABETES TREATMENT- HIGH CVD RISK
1ST LINE?
ONCE TOLERATED?
IF NOT TOLERATED?
1ST LINE? METFORMIN
ONCE TOLERATED? ADD SLGT-2i
IF NOT TOLERATED? ALONE SLGT-2i
why is sglt2i good in diabetes with high cvd risk?
cardio protective
DIABETES TREATMENT- HIGH CVD RISK
what to do if HBA1C> individually agreed threshold?
SAME AS DUAL+TRIPLE THERAPY FLASHCARDS!
avoid pioglitazone due to cvd risk
Patient w/ diabetes develops high risk CVD at any point what to do?
Consider SLGT-2i first.
EU marketing agency, recent approval for flozins in HF, draining effect.
TREATMENT OF DIABETES- METFORMIN RESISTANCE
Patient can’t tolerate metformin due to side-effects?
Use MR preparations
TREATMENT OF DIABETES- METFORMIN RESISTANCE
Patient can’t tolerate metformin MR? Treat w/…
BUT
When high risk of CVD?
Treat w/ DPP-4I/Pioglitazone/SU/SLGLT-2I
BUT
When high risk of CVD? SGLT-2i
TREATMENT OF DIABETES- METFORMIN RESISTANCE
HbA1c above individually agreed threshold& Monotherapy not working?
Treat w/…
Treat w/…
DPP-4i+Piogltiazone
OR
DPP-4i+SU
OR
Pioglitazone+SU
TREATMENT OF DIABETES- METFORMIN RESISTANCE
HbA1c STILL not controlled..?
INSULIN THERAPY!
METFORMIN (biguanide)
MOA?
Decreases gluconeogenesis+increases peripheral utilisation of glucose
METFORMIN SIDE-EFFECTS? LGV
Lactic acidosis (avoid if eGFR<30)
GI side-effects (increase dose slowly/give MR prep)
Can reduce vitamin B12
why can metformin -> lactic acidosis?
metformin blocks pyruvated carboxylases -> enz involved in gluconeogenesis, thus leading to accumulation of lactic acid
sick day rules apply to which classes of drugs?
diuretics
acei/ arb
metformin
nsaids
aglt2i
(all act on kidneys)
what to do if PATIENT ON METFORMIN experiences acute AKI?
stop!
due to increased risk of lactic acidosis
SULPHONYLUREAS
MOA?
S for secretion!
Stimulates insulin secretion from pancreatic beta cell
2 TYPES OF SULPHONYLUREAS? and examples pls
SHORT-ACTING- GT- gliclazide, tolbutamide, glipizide
LONG-ACTING- GG- glibenclamide, glimepiride
What are LONG-ACTING sulphonylureas associated with?
prolonged/sometimes fatal cases of hypoglycaemia
AVOID IN ELDERLY